John Nicoll

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

Ryan M. O’Connell, Dinesh S. Rao, Aadel A. Chaudhuri et al. · The Journal of Experimental Medicine · 2008 · 678 citations · Full text

Immunology, Pathology, Sustained Expression +23

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency

Neil P. Shah, Brian J. Skaggs, Susan Branford et al. · Journal of Clinical Investigation · 2007 · 413 citations · Full text

Abl Kinase Inhibitors, Mixed-phenotype Acute Leukemia, Tumor Biology +16

Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop

S. A. Roumiantsev, Neil P. Shah, M. Gorre et al. · Proceedings of the National Academy of Sciences · 2002 · 257 citations · Full text

Mixed-phenotype Acute Leukemia, Tumor Biology, Myeloid Neoplasia +17

Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis

Neil P. Shah, Corynn Kasap, Christopher Weier et al. · Cancer Cell · 2008 · 229 citations · Full text

Hematological Malignancy, Tumor Biology, Medicine +8